# Anika Therapeutics, Inc.: Form SC 13D/A, filed May 30, 2024

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: SC 13D/A
- Filed: 2024-05-30
- Accepted by EDGAR: May 30, 2024, 16:31 ET
- Period: not reported
- Accession: 0000902664-24-003936
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000090266424003936/p24-1952sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000090266424003936/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000090266424003936/p24-1952sc13da.htm

Filed May 30, 2024.
Source: SEC EDGAR, the filing index for accession 0000902664-24-003936. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.